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Six and 12 months’ effects of individual joint protection education in people with 
rheumatoid arthritis: A randomized controlled trial  
 
Abstract 
Background: Joint protection (JP) education for people with rheumatoid arthritis (RA) is effective 
when applying psycho-educational teaching strategies. The Pictorial Representation of Illness and 
Self Measure (PRISM) was used to identify relevant JP education goals and life aspects, both 
supporting motivation and behaviour change. The objective of this study was to compare the 
effects of individual JP education, PRISM-based (PRISM-JP) vs. conventional (C-JP) in people 
with rheumatoid arthritis (RA). 
Methods: An assessor-blinded randomized controlled trial was conducted in 4 rheumatology 
centres. Patients were randomized to PRISM-JP or C-JP, consisting of 5 JP education sessions 
over 3 months. Primary outcome was JP behaviour at 6 and 12 months.  
Results: A total of 53 RA patients participated. The PRISM-JP group (n=26) demonstrated 
significantly more JP behaviour at 6 months (effect size ES=0.32; p=0.02) and 12 months 
(ES=0.28; p=0.04) than the C-JP (n=27). Within group analysis showed that the JP intervention 
was successful at 6 and 12 months in both groups (p<0.001). At 12 months the PRISM-JP group 
had better JP self-efficacy (p=0.02) and grip strength (p=0.04) compared to baseline.   
Conclusion: PRISM-JP was more effective than C-JP in terms of long-term JP behaviour at six 
and 12 months.    
 
Key words: joint protection behaviour, patient education, Pictorial Representation of Illness and 
Self Measure (PRISM), occupational therapy, self-efficacy, hand therapy. 
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Introduction 
Joint protection (JP) education aims to teach ergonomic working methods which are based on JP 
principles such as reduce effort to do a job, distribute load over several joints, use joints in stable 
positions, use strongest, largest (proximal) joints, avoid positions of deformity, balance activity and 
rest [1]. Although effective drugs are available today, these principles are still valid, but the JP 
concept has developed from teaching ‘how to protect joints’ to a self-management approach ‘to 
improve daily tasks and role performance through the use of alternative working methods (e.g. 
working bilaterally, ergonomic adaptations, assistive devices), which may thus enhance 
perceptions of control and improve psychological status’ [2]. This current concept requires a 
psycho-educational approach to support behavioural changes. 
There is evidence that psycho-educational group joint protection (JP) interventions for people with 
rheumatoid arthritis (RA) are effective on JP adherence and hand functional abilities in the short- 
and long-term [2-4]. These results support the importance of occupational therapy and hand JP 
education in the management of people with RA. In Switzerland JP education is usually provided in 
a one-on-one approach. It is currently unclear, whether the effects of psycho-educational JP 
education in group settings are applicable to an individual approach. Furthermore, despite the fact 
that JP research consistently has demonstrated the superiority of psycho-educational teaching 
strategies, the implementation of this approach requires special attention [5] . Also in Switzerland, 
occupational therapists predominantly apply an educational approach in JP education, providing 
knowledge and skills by use of conventional teaching methods. Conventional teaching methods 
include giving information, demonstrations and supervised practice of JP methods.  
The challenge in JP education is not only to achieve short-time learning effects, but moreover 
behavioural changes and long-term adherence. However, conventional teaching strategies usually 
do not achieve these aims [6, 7]. Adherence, i.e. performing a behaviour sufficiently and long 
enough to be effective, may determine the outcome of an intervention. Several reasons were 
identified for not adhering to JP: perception of not being capable of implementing JP behaviour, 
lack of motivation, not perceiving benefit of adhering, insufficient or inconsistent advice from health 
professionals and lack of time [8].  
The Pictorial Representation of Illness and Self Measure (PRISM) was used to guide an 
individual approach in JP education [9]. PRISM is a brief interactive hands-on tool, requiring simple 
instructions and little time. The standard PRISM task was developed to quantitatively and 
qualitatively assess a person’s suffering caused by an illness and/or pain [10, 11]. This perceived 
impact of disease is related to restrictions or losses in aspects of life that are most salient for that 
person. An extension of the tool (PRISM+ task) visually summarizes relationships between illness 
and other important aspects of the patient’s life (e.g. work, family, hobbies, friends). In routine [12] 
as well as specialized [13] clinical care for patients with physical illness PRISM has demonstrated 
high therapeutic potential in reinforcing a client-centred approach.  
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In this study we tested the hypothesis that individual, PRISM-facilitated and resource-oriented 
JP education (PRISM-JP) in RA patients would improve JP behaviour and adherence compared to 
conventional JP education (C-JP) up to twelve months after the JP-intervention. We assumed that 
that the client-centred approach applied by PRISM, with focus on meaningful tasks and attractive 
goals would enhance patients’ motivation for collaboration and be an efficient way of improving 
transfer of JP education to daily life  [14].  
At 3-months follow up both groups improved in JP behaviour, the PRISM-JP group additionally 
improved in pain scores, arthritis self-efficacy and JP self-efficacy [15].  This publication reports on 
JP behaviour and other outcomes at the 6 and 12 months follow up.   
 
Methods 
Design and randomisation 
A multicentre randomized controlled trial was conducted, according to the extended CONSORT 
statement to randomized trials of non-pharmacologic treatment [16].   
Randomisation was stratified for each centre and a four-block sequence [17] was performed at 
each centre to ensure balanced allocation to the two groups. Patients were randomly assigned to 
C-JP or PRISM-JP using sequentially numbered, concealed treatment allocations prepared in 
advance. Blinding of treating occupational therapists (OTs) and patients was not feasible, but the 
assessor rating the primary outcome (JP behaviour) was blinded.  
Patients  
Eligible Patients had to be: diagnosed with RA according to ACR guidelines [18]; in ACR functional 
class ll (limited in avocational activities), lll (limited in vocational and avocational activities) or IV 
(limited in usual self-care, vocational, and avocational activities) [19]; perceiving difficulties and/or 
pain in hands that justified occupational therapy, and sufficient German language skills. Severe 
deformities of finger, hand and shoulder joints were exclusion criteria, as for these patients more 
idiosyncratic JP methods have to be found. Patients were included between July 2006 and 
February 2008. They were asked to participate in a study aiming to evaluate two different 
educational approaches within occupational therapy, but they were not informed that the focus was 
on JP behaviour. Ethical approval was obtained in all regions involved and patients provided 
informed consent prior to participation. The study was registered in Clinical.Trials.gov. 
Participating centres and care providers  
Four rheumatology centres, among them two university hospitals, one rheumatology-orthopaedic 
centre and one rheumatology rehabilitation clinic, in German-speaking regions of Switzerland 
participated. Two experienced rheumatology occupational therapists (OTs) in each centre 
participated and provided the C-JP or the PRISM-JP. The expertise in providing JP education to 
people with RA required from the participating occupational therapists (OTs) ought to minimize 
bias of possible treatment effect estimates due to different experience in treating such patients 
[20]. The OTs providing the experimental JP (PRISM-JP) were trained by two researchers (SB, 
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KN),  an OT experienced in PRISM use and a research patient partner in a two-day course, and 
regular supervision meetings were held to ensure correct application of PRISM interventions during 
study. Furthermore, OTs were asked not to discuss treatment or participants among each other. 
The interventions consisted of five 45-minutes sessions, four over a three weeks period and one 
booster session two months later.  
The C-JP 
The C-JP consisted of JP education previously standardised over the four centres and summarised 
in a short manual: oral and written information about RA and JP-principles [1]; demonstrations and 
supervised practice of hand JP methods, mostly in kitchen activities, and demonstration of 
appropriate assistive devices. ‘Preparing instant coffee’ was the assessed primary outcome activity 
and therefore not allowed as a practicing example [21]. OTs further documented any additional 
intervention in written form (e.g. home exercise, final provision of assistive devices, splints).   
The PRISM-JP 
The PRISM-JP consisted of the same JP education content, but was based on the PRISM tasks 
(PRSIM standard and PRISM+) as well as the theories of social learning [22] and self-
management [23] to individualize the JP education and to support motivation for using JP methods.  
When performing the standard PRISM task, the patient is shown a white A4-sized board with a 
fixed yellow disk (7cm in diameter) at the bottom right corner and is asked to imagine that the 
board represents his/her life as it currently is, and the disk represents his/her “Self”. The person is 
then handed a red disk, 5 cm in diameter, representing his/her “Illness” and asked to place this 
illness disk where it reflects the perceived burden of illness in his/her life at present. The distance, 
in centimetres, between the centres of the “Illness” and the “Self” disks (range 0-27 cm) is the 
“Self-Illness Separation” (SIS). A smaller distance indicates higher impact of the disease, i.e. more 
suffering (Figure 1) [10].  
When performing the PRISM+ task, further disks, similar to the illness disk but of different colours, 
represent important aspects of the patient’s life (e.g. leisure activities or social activities), 
summarising relationships between the illness and other aspects of the patient’s life in visual form 
[12]. The “Self-Resource Separation” (SRS; range 0-27 cm) is used accordingly but its 
interpretation is different from the SIS: a larger distance indicates a less positive impact (of life 
aspects), thus possibly a resource/life aspect that should get more attention. By this, a smaller 
SRS indicates a more positive impact. 
The contents of the PRISM-JP interventions were allocated to the sessions 1 to 5 and summarized  
in a short manual to guide the interventions. The contents of the C-JP were not allocated to 
specific sessions. 
In session 1, the standard PRISM task was used to identify tasks where performance was difficult 
due to RA. After placing the illness disk SIS was measured and the patient was asked to describe 
in which activities and why problems occurred. JP education and JP practice were linked with 
these individually relevant tasks.   
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In session 2, The PRISM+ task helped find an individual resource to care for during the therapy 
process. After putting their resource disks (for study purposes previously framed as: 1) personal 
care, 2) work, 3) family/friends, 4) leisure activities) the patient was asked which resource (s)he 
considered the most important to pay attention to during the therapy process. SRS was measured. 
The resource was not to be related to illness related problems and JP activities but to perceived 
positive activities, e.g. listening music, going to cinema, activities with friends and family. The idea 
was to support motivation for JP behaviour by additional focus on a life aspect that represented 
positive memories for the patient. 
In sessions 3 and 4, the selected resource was evaluated and reinforced.  
In session 5, after the 3-months follow up assessment, the 2-month in-between period was 
evaluated by applying the PRISM tasks and, based on this, JP methods and key messages were 
repeated, including the patient’s choice of activity, reinforcement of successful application and 
problem-solving for perceived barriers.   
JP education and practice were part of every session. They became progressively complex, 
starting with self-monitoring of hand use and activities causing pain and difficulties; proceeding 
onto selecting one or several JP principle(s) to applying (referring to life areas defined in session 1) 
and practicing JP methods within individually selected complex activities and discussing and 
applying transfer of JP methods to other activities. Energy conservation was addressed in sessions 
4 and 5.  
Homework tasks consisted of reading booklets about RA and JP methods, edited by the Swiss 
League Against Rheumatism, practicing selected JP methods and the same complex JP activity, 
applying selected JP principles to various situations in short- and mid-term  (between session 4 
and follow up assessment). Mutual goal agreement on homework tasks and self-monitoring were 
important integral parts. Homework was evaluated at the beginning of the subsequent session, 
where facilitators, barriers and possible solutions were discussed. In session 5, patients were 
asked to define mid and long-term goals, i.e. at 6 and 12 months, with the idea of supporting 
adherence by directing the attention on a longer-term perspective. 
Social support: participants were encouraged to discuss the reading material with their partners 
and invite them to participate in sessions 4 and 5.  
 
Outcomes and outcome measures 
Comprehensive assessments at baseline (T0) and 6 (T1) and 12-months (T2) follow ups were 
administered.  
Primary outcome measure 
Joint protection behaviour: was assessed using the German version of the Joint Protection 
Behavioural Assessment D-JPBA-S [21]. A research assistant videotaped nine tasks required for 
the activity ‘preparing instant coffee’ (e.g. turning tap, carrying pan, opening coffee jar), transferred 
the videorecordings to Pinnacle Instant CD/DVD 11.0 software (Pinnacle systems, Mountain View, 
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CA) and edited them in a mixed sequence on compact discs for assessment. One experienced 
rheumatology OT, blinded to the patients’ treatment allocation and time point of recording, rated 
the use of JP methods in all nine tasks on a 0-2 point scale (2=correct, 1=partially correct, 0= 
incorrect; with a total score of 18), following the instructions of the manual. 
 
Secondary outcome measures 
Hand function: Grip strength for the dominant hand was measured using a Jamar hand 
dynamometer [24] and hand pain was assessed on a 0-10 VAS scale (0=no pain, 10=maximal 
pain) by the research assistant, before or after the videorecording.   
 
A set of questionnaires, all validated in the German language was used. The total score of each 
scale is equal to the mean value of all subscores, unless otherwise stated. 
Self-efficacy 
• Arthritis self-efficacy scale, German Version A-SES-D, a 8-item self-administered 
questionnaire, assessing the perceived pain and ability to control the arthritis on a 0-10 
VAS scale (0=very uncertain, 10=very certain) [25] 
• JP-specific self-efficacy, a 10-item scale assessing perceived ability to perform JP across a 
variety of situations on a 0-3 point scale (0= not at all confident; 3 very confident), with a  
total score of 30 [26].  
Quality of life 
• EUROHIS-QUOL 8, an 8-item WHO quality of life questionnaire assessing general quality 
of life  on a 0-4 Likert scale (0= not at all satisfied; 4 completely satisfied) [27]. 
• Hospital Anxiety and depression Scale, German Version, HADS-D, assessing anxiety and 
depression on two 7-item scales scoring 0-3 (0= no problem; 3 severe problems) [28]. 
Other data assessed  
Patients’ and disease characteristics were measured at baseline. Drug treatment and disease 
activity were assessed at baseline and 12 months follow up.  
• Disease activity: using the Disease Activity Score (DAS28), calculated from the results of a 
28 tender joint count, a 28 swollen joint count and erythrocyte sedimentation rate [29]. 
DAS28 was assessed by rheumatologists not aware of patients’ treatment allocation. 
 
PRISM-data (PRISM-JP group only) 
Self-Illness Separation SIS, derived from the PRISM task (perceived burden of illness) and Self-
Resource Separation SRS derived from the PRISM+ task (resource activation) were assessed for 
the intervention group.  
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Statistics 
Sample size calculations [30] were based on data from the D-JPBA-S validation study [21]. A 
minimum of 22 participants in each group was needed to detect a 20% difference in joint protection 
behaviour scores, assuming a mean change of 5.5 points (SD 3.7) on a linear scale, power of 90% 
and significance level of 0.05. A 20% drop out rate was added and to reach the same even number 
over the 4 centres, inclusion of 56 patients was necessary.  
Rasch analysis was performed on the D-JPBA-S and JP-SES data to convert the ordinal raw data 
to interval scaled data [21, 31]. For each assessment, the data of the different time points were 
transformed within the same frame of reference [32]. To evaluate real changes in clinical practice 
and research, a test–retest change determined by a specific measurement must be at least the 
smallest detectable difference (SDD) [33], which was 5.5 points for the D-JPBA-S [21]. For both 
groups, the number of patients above the SDD was calculated, the difference between the two 
groups was assessed by a Chi square test.    
Intention to treat analysis was performed. Missing values at 6 months were imputed with the values 
of baseline (3 cases); missing values at 12 months were imputed with the values at 6 months 
where available (1 case), otherwise with baseline values (1 case) (see Figure 2). Effect sizes were 
calculated based on the standardized difference between two means [34] 
To analyse the between-group differences of the JP interventions on JP behaviour, self-efficacy 
and hand function after 6 and 12 months, we performed an analysis of absolute change (follow up 
minus baseline values), using analysis of variance, correcting for baseline values (ANCOVA). The 
results are presented as a mean difference in change between the groups. Paired t-tests were 
applied for within group comparisons at 12 months where appropriate.  
 
Results 
Flow of participants through study is presented in Figure 2: the number of eligible patients is a 
retrospective estimation, as it was not feasible to establish a systematic reporting of eligible 
patients in all involved centres. Recruiting all patients took approximately 1.5 years. Distribution of 
treated patients was unequal over the 4 centres (14 / 15 / 24 / 1 patients), but equally distributed 
between C-JP and PRISM-JP within the centres. The rheumatology rehabilitation clinic recruited 
only one patient over 8 months and stopped participation when the OT trained for providing the 
PRISM-JP changed job. 
The participants of the two groups were well matched in relation to demographic and clinical data 
(Table 1). The average age and disease duration of the experimental patients were higher and 
consequently the average professional work frequency was lower compared to the controls.  
Drug treatment. In both groups, the initial rate of patients on biologicals (anti-TNF and Rituximab) 
disease-modifying anti-rheumatic drugs (DMARDs), non-steroidal anti-inflammatory drugs 
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(NSAIDs), glucocorticoids and analgetics was similar. About one third of the patients in both groups 
received combination therapy of biologicals and DMARDs initially and after one year (Table 2).  
Adherence to treatment and follow up. One patient (PRISM-JP) did not attend all JP sessions (2 
out of 4) and the follow up sessions, because travelling was too stressful; but she did fill out all 
questionnaires. Two other patients of the PRISM-JP group did not attend the follow up 
assessments at 6 months, but both accepted to participate at the 12-months follow up.  At the 12 
months follow up one patient from the C-JP group was unable to participate. One patient of the 
PRISM-JP group brought a relative (adult daughter) to session 4.  
Additional treatment. Eight patients received additional OT after the intervention period, three in 
the PRISM-JP group and five in the C-JP group. Two patients received work place adaptation and 
counselling, two had static splints for night use, one finger splints; three patients (2 C-JP, 1 PRISM 
JP) underwent hand surgery (wrist arthrodesis), shortly after the 6-months follow up.  
 
6 months follow up 
Improvement of JP behaviour in the PRISM-JP group was significantly larger compared to the C-
JP group (effect size (ES) 0.32, p=0.02) (Table 3). In the PRISM-JP group, 14 patients (53%) 
increased JP behaviour scores by more than 30% (i.e. by more than 5.4 points, which corresponds 
to the smallest detectable difference SDD of the D-JPBA-S), whereas in the C-JP group, 5 patients 
(19%) increased by more than 30%. This difference was significant (p=0.008). 
However, JP behaviour increased significantly in both groups from baseline to 6 months follow up 
(p<0.001).  
JP-self-efficacy was significantly increased in both groups. No further differences between or within 
the groups on any variables were present.  
12-months follow up 
At 12 months follow up, there was significantly better JP adherence in the PRISM group compared 
to the C-JP group (effect size 0.28, p=0.04) (Table 3). Considerably more PRISM-JP participants 
increased JP behaviour by more than 30% (i.e. above the SDD) from baseline, i.e. 14 patients, 
compared to 5 patients in the C-JP group (p=0.008). 
However again both groups showed more use of JP methods (p<0.001) compared to baseline.  
 The C-JP group had significantly better quality of life scores at 12 months compared to the 
PRISM-JP group. Within group analysis showed improved JP specific self-efficacy (p=0.02) and 
improved grip strength (p=0.04) in the PRISM-JP group, whereas the C-JP group had improved 
scores in depression (HADS-D), quality of life (EUROHIS QUOL 8) and disease activity (DAS28). 
(Table 3). 
Subanalysis of PRISM-JP group 
No change in PRISM-measured perceived burden of disease and resource activation occurred at 6 
and 12 months (Table 4). 
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Discussion 
The study showed that individual JP education increased JP behaviour at 6 and 12 months. 
Overall, PRISM-JP was more effective than C-JP. Continued adherence was high in the PRISM-JP 
group. At 12 months, the PRISM group showed increased JP-self efficacy and grip strength, which 
may be directly linked with continuously performing JP methods in a possibly sufficient amount. 
This confirmed previous evidence that a psycho-educational teaching approach is more successful 
than a conventional one, and confirmed our hypothesis that this may apply also in individual JP 
education.  
Interestingly, average use of JP methods was also significantly increased in the C-JP group at 6 
and 12 months. This is remarkable and different to what was observed in another JP study, where 
there were no effects on JP behaviour in the conventional JP education group at 12-months follow 
up [4]. In contrast to that study, our participants had established RA and both interventions, PRISM-
JP and C-JP, focused on JP behaviour and had the same duration. It may also be that a one-on-
one approach has beneficial effects that outweigh the well-known advantages of group intervention 
i.e. group interaction and participants modelling [35]. Although the effect sizes were small in favour 
of the PRISM-JP education, it is remarkable that JP behaviour was sustained in both groups at 6 
and 12 months.  
However, although participants in both groups increased their JP behaviour significantly, only about 
50% of the PRISM group and approximately 20% of the control group improved above the 
measurement error (SDD) of the D-JPBA-S scale.  
Beyond the measurement error there is the minimal clinically significant difference, which is the 
‘smallest difference in a score in a domain of interest that patients perceive as beneficial’ [36]. In JP 
behaviour, perceived benefits are less pain or better function; however, we do not know which 
improvements in JP use in which tasks reflect these benefits. In the PRISM-JP group, the JP 
education tasks were linked to individually meaningful and relevant activities and most often leisure 
activities were selected [37]. By this, immediate benefit could be perceived which was considered a 
strong motivation. The C-JP used more ‘purposeful’ activities (kitchen household, self-care). 
In contrast to comparable JP studies [2, 4], the D-JPBA-S assessment activity, preparing instant 
coffee, was not allowed as practice example in either group. Hammond stated that it was unknown 
to what degree patients were able to transfer the JP behaviour assessed by the JPBA to their 
individual daily activities [4]. In our study, transfer from a practice activity to the assessment activity 
seemed to have happened in both treatment groups, but more successfully in the PRISM-JP group. 
The increased JP self-efficacy in both groups at 6 months may indicate that the participants felt 
confident to perform JP across a variety of situations. Interestingly, JP self-efficacy was larger in 
the PRISM-JP group at 12 months compared to 6 months, although not significantly different to the 
C-JP group.   
Improved grip strength in the PRISM-JP group at 12 months follow up was shown. Although JP 
behaviour is not considered to improve grip strength, but rather to facilitate tasks by working with 
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less stress and effort, strength did improve [1]. This is in accordance with findings in patients with 
early RA [4]. Possibly the more regularly JP methods are applied, the easier and possibly with less 
pain tasks are performed. As a consequence this may increase the amount of activity and thus grip 
strength.  
Medication aims to decrease disease activity, however the PRISM group’s disease activity 
(measured by DAS28) did not decrease. Increased grip strength and less perceived disease 
activity (measured by RADAI questionnaire) is thus more likely to be attributable to JP education 
than to the drug treatment. On the other hand, the C-JP group showed significant improvements in 
DAS28, depression and quality of life. The reduced disease activity in this group was more 
probably related to positive drug treatment response than to a direct consequence of JP education, 
even more when considering the decreased JP adherence in this group between 6 and 12 months. 
Participants of the C-JP group were younger and had shorter disease duration. When they 
presented at a specialized rheumatology clinic in a stage of exacerbated disease activity, they were 
likely to be successfully treated with biologicals, which may subsequently have lead to reduced 
depression and perceived better quality of life.  
The study has its limitations. One was the recruiting of patients at rheumatology centres. It can be 
assumed that patients who are treated by early use of TNF and combination therapies are more 
present in specialised clinics than in general rheumatology practices, and therefore not represent 
the typical general RA population. Moreover, these clinics represent high volume centres, this may 
indicate that the generalisibility of our findings depend on the OTs’ experience and routine [20]. 
Another limitation is that sample size was calculated for the primary outcome of JP behaviour, but 
not for hand function, self-efficacy and psychological health, and thus study size prevented 
detection of further differences. 
However, the PRISM intervention demonstrated to be appropriate for occupational therapy 
interventions, meeting important OT concepts. Meaningful occupations [37] to practice JP methods 
were identified by the PRISM standard task assessing life areas were burden of illness was 
perceived and by PRISM+ task identifying the resource to support the therapy process. This 
ensured an individualized client-centred therapeutic approach. The aim of the PRISM intervention 
was to increase and support motivation and although there were no differences measured in the 
PRISM tasks, we assume that group differences may be explained by this approach. PRISM 
enhanced patient-therapist communication of individual aspects of illness, and enriched and 
improved the therapeutic process with salient information. After a two-day training, OTs were able 
to perform the PRISM tasks and to take advantage on this approach. We suggest the use of 
PRISM in routine clinical practice, not restricted to RA or rheumatology patients. 
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Table 1: Demographic and clinical baseline variables of study participants (n=53) 
 Conventional JP 
education 
(n= 27) 
PRISM-based JP 
education 
(n=26) 
Females, no. (%) 22 (82%) 22 (85%) 
Age, years, mean (SD)  53.44 (15.71) 62.08 (12.61) 
Disease duration, years, mean (SD)   8.30 (9.75) 10.23 (7.64) 
Patients < 65 years / with work ability (%) 
Weekly working hours, mean (SD) 
22 / 14 (64%) 
31.5 (12.31) 
17 / 10 (59%) 
22 (14.22) 
Former OT/mean years since (SD)   4 / 5.75 (5.74)   6 / 8.17 (4.62) 
Rheumatoid nodules (%)   3 (11%)   2 (8%) 
Rheumatoid factor (%) 18 (66%) 20 (77%) 
ANA (%) 15 (56%) 16 (62%) 
Erosions (%) 15 (56%) 18 (69%) 
All values represent the number of patients and proportions (%), unless stated otherwise.  
ANA = anti-nuclear antibodies.  
Table 2. Drug therapy at baseline and 12 months follow up  
 Conventional  
joint protection  
education (C-JP) 
PRISM-based  
 joint protection  
education (PRISM-JP) 
 Baseline 
n=27 
12 months  
n=27 
Baseline 
n=26 
12 months 
n=26 
Biologicals  
DMARDs  
Steroids  
NSAIDs  
Analgetics  
  8 (30%) 
22 (82%) 
11 (41%) 
  9 (33%) 
  7 (26%) 
  9 (33%) 
21 (78%) 
10 (37%) 
  6 (22%) 
  2 (7%) 
  9 (33%) 
20 (77%) 
13 (50%) 
11 (42%) 
  2 (8%) 
11 (41%) 
22 (82%) 
11 (41%) 
  9 (33%) 
  2 (8%) 
 
All numbers are number of patients and proportions 
‘Biologicals’ encompass Anti-TNF and Rituximab drugs; DMARDs = disease-modifying anti-
rheumatic drugs; NSAIDs = non-steroidal anti-inflammatory drugs.  
Table 3. Primary and secondary outcome variables: at baseline and mean changes (standard deviation SD) at 6 and 12 months follow up  
 Conventional joint protection education PRISM-based joint protection education ∆ between 
groups       
6 months 
∆ between 
groups        
12 months 
 Baseline  
(n=27) 
6 months 
change  (n=27) 
12 months 
change (n=27) 
Baseline 
(n=26) 
6 months 
change (n=26) 
12 months 
Change (n=26) 
p-value p-value 
D-JPBA-S (0-18)   4.01 (3.89)   3.0 (3.4) ***b) 2.8 (3.1) ***b)   3.78 (4.59) 5.4 (3.8) ***b) 4.8 (3.8) ***b) 0.02 0.04 
ASES-D (0-10)   7.12 (1.56) -0.4 (1.8) -0.5 (1.6)   6.51 (2.07)  0.1 (2.0) -0.1 (1.9) 0.31 0.38 
JP-SES (0-30) 16.24 (6.10)  3.1 (4.6) **b) 1.9 (5.2) 16.59 (5.21)  2.5 (5.7) *b) 3.3 (6.9) *b) 0.70 0.39 
Hand pain# (0-10)   2.89 (2.98)  0.44 (2.22) -0.44 (2.34)   3.08 (3.06) -0.15 (2.68) -0.28 (2.62) 0.38 0.82 
Grip strength# (>0) 15.50 (9.46)  1.3 (4.3)  0.2 (6.0) 14.88 (9.36)  2.0 (6.0)  2.9 (6.8) *b) 0.62 0.13 
HADS-A (0-21) 
HADS-D (0-21) 
  4.33 (2.92) 
  4.33 (3.16) 
-0.1 (2.7) 
-0.3 (2.9) 
 0.0 (2.2) 
-0.8 (2.2) *b) 
  6.92 (4.33) 
  5.27 (3.32) 
-0.4 (3.0) 
-0.3 (2.4) 
-0.1 (2.9) 
 0.5 (3.0) 
0.73 
0.97 
0.89 
0.09 
EUROHIS-QOL-8  
(0-4) 
  2.71 (0.67)  0.05 (0.53)  0.18 (0.42) *b)   2.61 (0.49)  0.06 (0.51) -0.09 (0.50) 0.94 0.04 
DAS28 (>0)   3.72 (1.67) NA -0.67 (1.60) *b)   3.70 (1.67) NA -0.33 (1.23) NA 0.39 
D-JPBA-S = JP Behavioural Assessment; ASES-D = Arthritis Self-Efficacy Scale; JP-SES = JP Self-Efficacy Scale; hand pain and grip strength (in 
kg), # of dominant hand; HADS = Hospital Anxiety and Depressions Scale (-D = Depression; -A = Anxiety subscale); EUROHIS-QOL-8 = Quality of 
Life 8 Item Index; DAS28 = Disease Activity Score in 28 joints;  
Significance level for between-group analysis:  p ≤ 0.05;    
Significance level for within-group analysis: *b) p ≤ 0.05;  **b) p ≤ 0.01  ***b) p< 0.001 (all compared to baseline)  
ANCOVA was applied for calculating between group changes from baseline to 6 and 12 months follow up, correcting for baseline values for all 
variables 
Paired samples t-tests for calculating within group change from baseline to 6 and 12 months follow up for all variables 
Table 4: PRISM perceived impact of illness (SIS) and impact of resource (SRS) (Intervention 
group) 
 Baseline 6 months  12 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Within group p
(6 months) 
Within group     
p (12 months) 
PRISM task 
(SIS) 
12.60 (8.5) 13.5 (7.5) 13.7 (7.1) 0.6 0.5 
PRISM+ task 
(SRS) 
10.0 (7.2) 8.0 (4.6) 8.1 (5.3) 0.1 0.2 
 
SIS (Self - Illness Separation) = measured distance between ‘Self’ and ‘Illness’ (in PRISM 
task)  
SRS (Self - Resource Separation) = measured distance between ‘Self’ and ‘Resource’ (in 
PRISM+ task) 
SIS:: an increasing SIS indicates lower impact of the illness (or perceived burden of illness) 
SRS: a decreasing SRS indicates a more positive impact of the resource 
Paired samples t-tests were applied for calculating change from baseline to follow up at 6 
and 12 months 
